Ryan Cohlhepp, President and COO at Bicara Therapeutics Inc. (BCAX), sold 12,500 shares at $18.68 ($234K) on 2025-12-15, disclosed to the SEC on 2025-12-16.
Scheduled sale ($234k) by President and COO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $18.68 | 4,500 | $84K | 36.0% |
| 2 | $18.68 | 8,000 | $149K | 64.0% |
| Total | $18.68 avg | 12,500 | $234K | 100% |
| Filing → |
| BCAX | SELL | 2026-07-10 | $833K | — | Filing → |
| BCAX | SELL | 2026-05-18 | $254K | — | Filing → |
| BCAX | SELL | 2026-04-17 | $288K | — | Filing → |